BIOMAT Database Logo BIOMAT Database Logo

[Possibilities of reducing the hospital-stage chemotherapy of patients with fibro-cavernous pulmonary tuberculosis]. 1985

A N Naubet'iarova, and M Kh Alibekova

UI MeSH Term Description Entries
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

A N Naubet'iarova, and M Kh Alibekova
[Prolonged chemotherapy in dispensary patients with fibro-cavernous pulmonary tuberculosis].
January 1967, Problemy tuberkuleza,
A N Naubet'iarova, and M Kh Alibekova
[Single-stage cavernoplasty in patients with fibro-cavernous pulmonary tuberculosis].
January 1986, Grudnaia khirurgiia (Moscow, Russia),
A N Naubet'iarova, and M Kh Alibekova
[Present possibilities of surgical treatment of patients with chronic fibro-cavernous pulmonary tuberculosis].
March 1967, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
A N Naubet'iarova, and M Kh Alibekova
[Analysis of chemotherapy with 2d line drugs in patients with chronic fibro-cavernous pulmonary tuberculosis].
January 1971, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
A N Naubet'iarova, and M Kh Alibekova
[Clinico-radiological classification and possibilities of therapy of patients with fibro-cavernous tuberculosis].
January 1969, Problemy tuberkuleza,
A N Naubet'iarova, and M Kh Alibekova
[Effectiveness of surgery in patients with disseminated fibro-cavernous pulmonary tuberculosis].
January 1967, Problemy tuberkuleza,
A N Naubet'iarova, and M Kh Alibekova
[Intermittent chemotherapy of patients with fibrous-cavernous pulmonary tuberculosis in a hospital].
January 1987, Problemy tuberkuleza,
A N Naubet'iarova, and M Kh Alibekova
[Relationship between bronchial and pulmonary changes in patients with fibro-cavernous pulmonary tuberculosis].
January 1975, Problemy tuberkuleza,
A N Naubet'iarova, and M Kh Alibekova
[Use of lidase in the treatment of patients with fibro-cavernous pulmonary tuberculosis].
January 1974, Problemy tuberkuleza,
A N Naubet'iarova, and M Kh Alibekova
[Cooperative clinical trials of efficacy of chemotherapy of patients with fibro-cavernous tuberculosis].
August 1982, Problemy tuberkuleza,
Copied contents to your clipboard!